Our News on Newswise

MD Anderson Research Highlights for September 21, 2023

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s...
21-Sep-2023 12:00 PM EDT Add to Favorites

Newswise: 650a102b491ee_SCRB5Rendering.jpg

MD Anderson expands breakthrough research campus with groundbreaking of innovative new facility

MD Anderson today broke ground on a 600,000-square-foot facility intended to anchor the institution’s expansive south campus research park. The building was purposefully built to enable collaborative science and impactful breakthrough discoveries...
20-Sep-2023 2:00 PM EDT Add to Favorites

Newswise: 65089a77c3479_eduardovilarsanchez.jpg.resize.810.1150.high.jpg

Exercise boosts anti-cancer immunity and reduces inflammation in Lynch Syndrome patients

Regular and intense aerobic exercise may reduce the risk of colorectal cancer in patients with Lynch Syndrome (LS) by improving the immune system's ability to detect and remove potentially harmful cells, according to researchers at The University...
19-Sep-2023 6:00 AM EDT Add to Favorites

Newswise: 6507a019ea760_wenjiang.jpg

Research identifies new potential hurdle for nano-based therapies

Researchers at The University of Texas MD Anderson Cancer Center have discovered that certain nano-based cancer therapies may be less effective in younger patients, highlighting the need for further investigation into the impact of aging on the...
17-Sep-2023 8:00 PM EDT Add to Favorites

Newswise: 6501daf5b1874_TinaCasconeMD.Ph.D..jpg

Combination immunotherapy treatment effective before lung cancer surgery

Combination immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab and other novel agents outperforms durvalumab alone in the neoadjuvant (pre-surgical) setting for early-stage non-small-cell lung cancer (NSCLC), according to researchers...
13-Sep-2023 2:00 PM EDT Add to Favorites

Newswise: 64ff5c104bb2d_StephenG.ChunMD.jpg

Intensity-modulated radiation therapy provides long-term benefits to patients with locally advanced lung cancer

Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the heart and lungs, according to researchers at The...
11-Sep-2023 3:00 PM EDT Add to Favorites

Enhanced recovery program successfully reduced opioid use after pancreatic cancer surgery

By improving hospital care pathways, researchers from The University of Texas MD Anderson Cancer Center successfully reduced inpatient opioid use by 50% after pancreatic cancer surgery and cut the median opioid prescription volumes at discharge to...
1-Sep-2023 11:05 AM EDT Add to Favorites

MD Anderson and Panacea launch Manaolana Oncology to develop antibody-based therapies for cancer

MD Anderson and Panacea Venture announced the launch of Manaolana Oncology, a new company created to develop and advance antibody-based therapies against novel cancer targets.
6-Sep-2023 8:00 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: BenjaminSmith.jpg

Mastectomy Plus Reconstruction Has Highest Rate of Complication, Complication-Related Costs of Guideline-Concordant Therapies for Early Breast Cancer

In a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age.
27-Sep-2016 3:05 PM EDT

Newswise: Liang_H_Bronto.jpg

Can Gender Play a Role in Determining Cancer Treatment Choices?

It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular level has been poorly understood.
9-May-2016 12:00 PM EDT

Newswise: ZhiminLu.jpg

MD Anderson Study Reveals New Insight Into Tumor Progression

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Newswise: Lee_M.jpg

Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6

A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

Newswise: 204929_Chhatwal_Jjpg.jpg

MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

See All Experts

Our YouTube Videos

About

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. The institution’s sole mission is to end cancer for patients and their families around the world, and, in 1971, it became one of the nation’s first National Cancer Institute (NCI)-designated comprehensive cancer centers. MD Anderson is No. 1 for cancer in U.S. News & World Report’s “Best Hospitals” rankings and has been named one of the nation’s top two hospitals for cancer since the rankings began in 1990. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).

Contacts

Aubrey Bloom
Program Manager, Public Relations

ARBloom@mdanderson.org

830-377-8566

Clayton Boldt
Program Director, Public Relations

CRBoldt@MDAnderson.org

713-792-9518

Andrea Bolt
Sr. Communications Specialist

ARBolt@MDAnderson.org

Katrina Burton
Program Manager, Public Relations

kburton@mdanderson.org

713-792-8034

Lany Kimmons
Program Manager, Public Relations

rlkimmons@mdanderson.org

713-563-5801

Jamie Mauracher
Program Manager

JRMauracher@MDAnderson.org

Julie Nagy
Program Manager, Public Relations

jenagy@mdanderson.org

713-563-3437

Elise Raymund
Sr. Communication Specialist

ERRaymund@mdanderson.org

346-725-0943

Allison Schaffer
Program Manager, Public Relations

ASchaffer@mdanderson.org

713-745-1357

Jade Waddy
Program Manager, Public Relations

JAWaddy@mdanderson.org

346-725-2126

Twitter

Instagram

Instagram feed not yet configured. Click "Edit Instagram Feed" to enter your Instagram details.
close
0.52963